International Patent: GLP-1R AND GCGR AGONIST IN THE TREATMENT OF ALCOHOL USE DISORDER (AUD) IN SUBJECTS WITH OBESITY OR OVERWEIGHT HUMAN BEINGS

GENEVA, Oct. 1 -- SPITFIRE PHARMA LLC filed a patent application (US2026/019123) for “GLP-1R AND GCGR AGONIST IN THE TREATMENT OF ALCOHOL USE DISORDER (AUD) IN SUBJECTS WITH OBESITY OR OVERWEIGHT HUMAN BEINGS”. With publication no. WO/2026/193405, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/26

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....